Electroconvulsive Therapy and Suicide

Suicide and Life‐Threatening Behavior

Volumn 16, Issue 2, 1986, Pages 198-222

  Tanney, Bryan L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

ADULT; AFFECTIVE NEUROSIS; CENTRAL NERVOUS SYSTEM; DELUSION; EDUCATION; EFFICACY; ELECTROCONVULSIVE THERAPY; ETIOLOGY; HUMAN; HUMAN EXPERIMENT; MENTAL DISEASE; PSYCHOLOGICAL ASPECT; SHORT SURVEY; SUICIDE; THERAPY;

ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; BRAIN DAMAGE, CHRONIC; COMPARATIVE STUDY; DELUSIONS; ELECTROCONVULSIVE THERAPY; FOLLOW-UP STUDIES; HUMAN; MEMORY DISORDERS; MENTAL DISORDERS; MOOD DISORDERS; RECURRENCE; SEIZURES; SUICIDE; SUICIDE, ATTEMPTED;

EID: 0022981098     PISSN: 03630234     EISSN: 1943278X     Source Type: Journal    
DOI: 10.1111/j.1943-278X.1986.tb00352.x     Document Type: Article

References (105)

1. Prediction of clinical response to ECT
2. Status epilepticus: Causes, clinical features and consequences in 98 patients
3. 5‐HIAA in the cerebrospinal fluid–‐a biochemical suicide predictor?
4. ECT in metropolitan New York hospitals: A survey of practice, 1975–76
5. Depression treated with imipramine and ECT: The DeCarolis study reconsidered
6. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants
7. The efficacy of electroconvulsive therapy and antidepressants in depression
8. Suicide, attempted suicide, and relapse rates in depression
9. Epidemiologic considerations in electroconvulsive therapy
10. A controlled trial of imipramine in treatment of depressive states
11. Suicide prevention, recurrent affective disorder, and lithium
12. A hundred cases of suicide: Clinical aspects
13. ECT in depression: The evidence of controlled studies
14. A study if suicides in a mental hospital
15. Prediction of tricyclic antidepressant response
16. A study of the incidence of epilepsy following ECT
17. Results of treatment in psychoses–‐with a control series
18. Electroconvulsive therapy: Results in depressive illness from the Leicestershire trial
19. ECT and antidepressant drugs in manic–depressive disease
20. A comparative trial of ECT and Tofranil
21. The diagnosis of depressive syndromes and the prediction of ECT response
22. Suicide during psychiatric hospitalization
23. Intrapatient responses to ECT and tricyclic antidepressants
24. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression
25. The Northwick Park ECT trial: Predictors of response to real and simulated ECT
26. Imipramine and electroshock in the treatment of depression: A clinical statistical analysis of 437 cases
27. Seizures after convulsive therapy: A retrospective case survey
28. A controlled comparison of electroconvulsive therapy, imipramine and thiopentone sleep in depression
29. A ten‐year followup study of electrocomatherapy
30. Efficacy and safety of induced seizures (EST) in man
31. Should ECT be reevaluated?
32. Unilateral ECT: Advantages and efficacy in the treatment of depression
33. Double‐blind controlled trial of electroconvulsive therapy (ECT) and simulated ECT in depressive illness
34. ECT: Patients' experiences and attitudes
35. Indications for electroconvulsive therapy and its use by senior psychiatrists
36. Depression, delusions and drug response
37. The Nottingham ECT study–‐a double‐blind comparison of bilateral, unilateral and simulated ECT in depressive illness
38. Differential response of hospitalized depressed patients to somatic therapy
39. Suicide and primary affective disorders
40. Factors related to the outcome of depression treated with ECT
41. A controlled trial of phenelzine in depressive reactions
42. Comparative trial of Ltryptophan and ECT in severe depressive illness
43. Prognostic factors in electric convulsive therapy
44. Are patients shocked by ECT?
45. Effect of tranquilizers on medical morbidity and mortality in a mental hospital
46. Involutional psychosis: Course when untreated and when treated with electric shock
47. Manic–depressive psychosis: Course when treated and untreated with electric shock
48. Prevention of fatalities in electroshock therapy
49. Electric and chemical convulsive therapy in psychiatry
50. Do tricyclic antidepressants work?
51. The Northwick Park ECT trial
52. Suicide risk in manic–depressive disorders
53. Proposal for a distinctive diagnosis: The deliberate self‐harm syndrome
54. A survey of attitudes on the use of electroconvulsive therapy
55. Evaluation of electric convulsive therapy as compared with conservative methods of treatment in depressive states
56. Prognostic factors in treatment of depressive states with imipramine
57. Endogenous depression treated with iproniazid–‐a followup study
58. Psychopharmaceuticals: Effects and side‐effects
59. Suicides, drugs and the open hospital
60. A controlled comparison of simulated and real ECT
61. Suicide in a state hospital for the mentally ill
62. Death due to treatment
63. ECT in the treatment of mania: A controlled study
64. Clinical trial of the treatment of depressive illness
65. Electroconvulsive therapy and depression: The prognostic significance of clinical factors
66. Analysis of temporal factors in manic–depressive psychosis, with particular reference to the effect of shock therapy
67. Psychological or physiological theories in ECT
68. Electroconvulsive shock treatment decreases beta adrenergic receptor sensitivity in rat brains
69. Depressive typolgies and responses to amitryptiline
70. Electroconvulsive treatment in Great Britain
71. Prognostic factors in the electroshock treatment of depressive states: Clinical features from testing and examination
72. A controlled trial of imipramine
73. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides
74. Depression, delusions, and suicide
75. Risk factors for suicide in psychiatric patients
76. ECT for acute mania: A forgotten treatment modality
77. An evaluation of shock therapy
78. A family study of suicide
79. Status of ECT: A review of the outcome literature
80. A comparison between the results of unmodified and modified electro‐plexy
81. Controlled trial of straight and modified electro‐plexy
82. Retrograde amnesia and bilateral ECT
83. Prognosis of depression with electrical treatment
84. Can ECT prevent premature death and suicide in schizoaffective patients?
85. The effectiveness and safety of electroconvulsive therapy (ECT)
86. Evaluation of convulsive and subconvulsive shock therapies utilizing a control group
87. Does ECT cause brain damage?
88. Electric convulsion therapy in depression: A double‐blind controlled trial
89. A controlled study of treatments of depression
90. Electroconvulsive treatment: A help for epileptics
91. Metrazol and electroconvulsive therapy of the affective psychoses